Walking patterns after knee replacement for knee osteoarthritis with the Empowr PS knee
Compares walking in people receiving the Empowr PS knee replacement with other knee designs.
Key facts
- Who runs it
- More Foundation
- Where
- Phoenix, United StatesSee the site
- Trial code
- Registry title
- Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- Status
- Recruiting
- People taking part
- 102 people, planned
- Started
- 2 Feb 2017
- Expected to end
- 2 Jan 2029
- Type of study
- Observational, 6 groups
- Treatments tested
- DJO Empowr PS Knee System
- Stryker Triathlon Total Knee System
- Biomet Vanguard Complete Knee System
- Control
- Record updated
- 6 May 2022
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with knee osteoarthritis who will get the DJO Empowr total knee replacement, plus healthy people of similar age as a comparison group. It also uses past walking data from people who got Stryker Triathlon or Biomet Vanguard knees.
- Age
- 50 years or older (for patients, at the time of surgery).
- Sex
- All sexes.
- Disease stage
- Patients must be able to have the DJO Empowr total knee replacement. Healthy comparison people must have no muscle, bone or joint injury or disorder.
- Earlier treatment
- Patients must be getting a first (primary) total knee replacement.
Main reasons for not taking part
- Inflammatory arthritis or psoriatic arthritis at the time of surgery.
- Being pregnant or planning to become pregnant.
- BMI over 40.
- Active or suspected hidden infection in or around the joint, or weak bone that cannot hold the implant.
- Mental or nerve-muscle disorders that raise the risk of implant problems, or severe knee instability from missing ligament function.
The registry criteria, word for word
Show all 29 criteriaShow less
Who can take part
- Controls:
- At least 50 years of age
- Subjects who provide signed and IRB approved informed consent for gait analysis data collection; Retrospective subjects:
- Subjects who had primary total knee replacement with either Stryker Triathlon Total Knee System or Biomet Vanguard Complete Knee System
- Subjects at least 50 years of age at the time of the surgery
- Subjects who previously provided signed and informed consent for gait analysis data collection under approval of the Sun Health Institutional Review Board
- Cases that followed product labeling; Prospective subjects:
- Subjects who are eligible for DJO Global's Empowr total knee replacement
- Subjects at least 50 years of age at the time of the surgery
- Subjects who are willing to provide signed and IRB approved informed consent for gait analysis data collection
- Cases that followed product labeling
Who cannot take part
- Subjects with inflammatory arthritis or psoriatic arthritis at the time of surgery
- Subjects whose bone stock was compromised by disease, infection or prior implantation which could not provide adequate support and/or fixation of the prosthesis
- Subjects with inflammatory arthritis or psoriatic arthritis at the time of surgery
- Subjects whose bone stock was compromised by disease, infection or prior implantation which could not provide adequate support and/or fixation of the prosthesis
- Controls with any musculoskeletal injury or disorder
- Subjects who had an active infection or suspected latent infection in or about the joint at the time of surgery
- Subjects who had any mental or neuromuscular disorders which created an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complication in postoperative care
- Subjects who had an active infection or suspected latent infection in or about the joint at the time of surgery
- Subjects who had any mental or neuromuscular disorders which created an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complication in postoperative care
- Controls:
- Controls that are pregnant or planning on becoming pregnant
- Controls with a BMI>40; Retrospective subjects:
- Subjects that are pregnant or planning on becoming pregnant
- Subjects with a BMI>40
- Subjects with severe instability of the knee joint secondary to the absence of collateral ligament integrity and function; Prospective subjects:
- Subjects that are pregnant or planning on becoming pregnant
- Subjects with a BMI>40
- Subjects with severe instability of the knee joint secondary to the absence of collateral ligament integrity and function
Where in United States
- MORE FoundationPhoenix, United StatesContact: John D McCamley, PhDTaking people
About the trial
What the trial wants to find out
Previous motion analysis studies have demonstrated excellent ability to distinguish subtle differences in gait between normal subjects and those suffering from arthritis. With proper techniques and analysis differences between osteoarthritis patient groups can be distinguished. Previous research has indicated that subjects who received a single-radius design total knee replacement have superior gait performance that those who received a multi-radius design total knee replacement. The DJO Global Empowr PS Knee System is a single-radius lateral pivot design. This design should achieve reproducible more natural knee function and improved patient outcomes and satisfaction. A motion analysis laboratory will be used to collect gait data from patients who are going to receive a Empowr PS knee device and also from age-matched control subjects. These data will be compared with data previously collected from patients who received Stryker Triathlon devices, Biomet Vanguard devices and age-matched healthy control subjects.
The 6 groups in the trial
- DJO subjects for surgical technique
Subjects who meet the inclusion criteria and receive a DJO Empowr total knee replacement but will not participate in motion data collection
Treatment: DJO Empowr PS Knee System
- DJO subjects for data collection
Subjects who meet the inclusion criteria and consent to be in the study will receive a DJO Empowr total knee replacement and participate in motion data collections at pre-op, and 6 and 12 months post-op. Subjects will also participate in pre-op, 6 month, 1 year, 2 year, 5 year, and 10 year post-op clinical data collections
Treatment: DJO Empowr PS Knee System
- Prospective control subjects
Healthy age matched subjects who did not have any knee osteoarthritis and participated in motion data collections.
Treatment: Control
- Stryker TKA subjects
Subjects who met the inclusion criteria and consented to be in a study whereby they received a Stryker Triathlon total knee replacement and participated in motion analysis pre-surgery and 6 and 12 months post-surgery.
Treatment: Stryker Triathlon Total Knee System
- Biomet TKA subjects
Subjects who met the inclusion criteria and consented to be in a study whereby they received a Biomet Vanguard total knee replacement and participated in motion analysis pre-surgery and 12 months post-surgery.
Treatment: Biomet Vanguard Complete Knee System
- Retrospective control subjects
Healthy age matched subjects who did not have any knee osteoarthritis and participated in motion data collections.
Treatment: Control
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- Plain-language title
- Walking patterns after knee replacement for knee osteoarthritis with the Empowr PS kneeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 6 May 2022